Font Size: a A A
Keyword [HER2]
Result: 1 - 20 | Page: 1 of 2
1. Carry Oxaliplatin, Herceptin Composite Metal Nanoparticles On Molecular Targeting HER2-positive Of Gastric
2. Separation Of Anti-HER2 And Anti-IL-12/23 Monoclonal Antibodies By Hydrophobic Charge-induction Chromatography
3. Production Of Recombinant Extracellular Domain Of Human HER2and Screening Of Specific VHH Nanobodies
4. Preparation, Activity In Vitro, Linker Based Optimization Of Recombinant Immunotoxin Gigantoxin-4-4D5 ScFv
5. Construction Of HER2-targeted DNA Nanocarriers Incorporating Polymeric 5-fluorodeoxyuridine And Their Antitumor Applications
6. Application Of Hydrophilic Modified Affinity Molecule Probe In HER2 Over Expression Breast Cancer
7. The HER2-Targeted Chemo-photothermal Combined Studies Of Aptamer-conjugated Mesoporous Silica-carbon Nanoparticles
8. Preparation And Imaging Investigation Of Dual-Targeted Poly(Lactic-Co-Glycolic Acid)Ultrasound Contrast Agent Carrying Anti-HER2 And VEGFR2 Antibodies
9. Nanostructure Surface Plasma Resonance Enhanced Fluorescence And Cellular Membrane HER2 Receptor Dimerization Inhibition Analysis
10. Investigations Of Molecular Imaging Probes From Radionuclide-and Fluorescent-labeled HER2 Nanobodies
11. Targeting MOFs Loaded With Fluorouracil Deoxynucleoside For Breast Cancer Treatment
12. Radioiodinated Small-Molecule Tyrosine Kinase Inhibitors For HER2-Selective SPECT Imaging Of Breast Cancer
13. Trastuzumab-decorated Multifunctional Polymersomes For Targeted Ovarian Cancer Chemotherapy
14. Studies On Preparation And Critical Factors Of Recombinant Anti-HER2 Antibody-Drug Conjugate
15. Radionuclide 68Ga And Fluorescence Labeled HER2 Nanobody Probes For The PET/NIRF Optical Imaging Of Cancer
16. Biochemical Characterization Of The Engineered Penetrative Nanobody Targeting Her2 Positive Breast Cancer Cells
17. The Development Of Conjugation Process For Anti-Her2 Antibody Drug Conjugate
18. Biodegradable Anti-HER2 Monoclonal Antibody/PCL-PEG/Paclitaxel Worm-like Nanocrystal Micelles For Treatment Of HER2-positive Breast Cancer
19. Study On Molecularly Imprinted Nanoparticles-based Cancer Targeted Therapy
20. Screening And Preliminary Evaluation Of Antibody-drug Conjugate (ADC) Targeting HER2+
  <<First  <Prev  Next>  Last>>  Jump to